• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Gabexate Mesylate

Gabexate Mesylate

Product ID G0104
Cas No. 56974-61-9
Purity ≥99%
Product Unit SizeCostQuantityStock
10 mg $155.80 In stock
100 mg $778.60 In stock
250 mg $1,557.20 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Gabexate displays anticancer chemotherapeutic, anti-angiogenic, anti-inflammatory, and antiviral activities. In vitro, gabexate inhibits the activation of NF-κB, ERK1/2, and Akt, downregulates the production of matrix metalloproteinases 2 and 9, VEGF, and IL-8, and increases expression of protein and phosphatase and tensin homolog (PTEN). Gabexate acts as a proteasome inhibitor, inhibiting activity of tumor-associated trypsinogen and urokinase-type plasminogen activator and decreasing the invasiveness of pancreatic cancer cells. Additionally, gabexate inhibits production of TNF-α, preventing activation of MAPK signaling cascades in vitro. This compound also exhibits antiviral activity against the influenza virus, inhibiting cleavage of hemagglutinin.

Product Info

Cas No.

56974-61-9

Purity

≥99%

Formula

C16H24N3O4 • CH3O3S

Formula Wt.

417.48

Chemical Name

ethyl 4-[6-(diaminomethylideneamino)hexanoyloxy]benzoate;methanesulfonic acid

IUPAC Name

ethyl 4-[6-(diaminomethylideneamino)hexanoyloxy]benzoate;methanesulfonic acid

Synonym

4-[[6-[ (aminoiminomethyl) amino]-1-oxohexyl]oxyl]benzoic acid ethyl ester mesylate salt

Melting Point

90-93℃

Appearance

White to off white powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

G0104 MSDS PDF

Info Sheet

G0104 Info Sheet PDF

References

Brandi G, Tavolari S, Guarnieri T, et al. Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. Pancreas. 2014 Jan;43(1):53-63. PMID: 24201777.

Hsieh HP, Hsu JT. Strategies of development of antiviral agents directed against influenza virus replication. Curr Pharm Des. 2007;13(34):3531-42. PMID: 18220789.

Uchima Y, Sawada T, Nishihara T, et al. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells. Pancreas. 2004 Aug;29(2):123-31. PMID: 15257104.

Yuksel M, Okajima K, Uchiba M, et al. Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappaB and activator protein-1 in human monocytes. J Pharmacol Exp Ther. 2003 Apr;305(1):298-305. PMID: 12649382.

Aosasa S, Ono S, Mochizuki H, et al. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock. 2001 Feb;15(2):101-5. PMID: 11220636.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • S5869

    Sorafenib Tosylate

    c-Raf, RET, VEGFR1 inhibitor, potential HMT inh...

    ≥99%
  • S3568

    Siramesine

    σ2 agonist.

    ≥98%
  • D3430

    Dihydrosanguinarine

    Benzophenanthridine alkaloid, sanguinarine meta...

    ≥98%
  • V0144

    n-Valeric Acid

    GHB/GABA analog found in Valeriana officinalis;...

    ≥99%
  • P3210

    Picoplatin

    Pt-based DNA cross-linker.

    ≥98%
  • A9715

    AZD-8330

    MEK 1/2 inhibitor.

    ≥98%
  • B8071

    3-tert-Butyl-4-Hydroxyanisole

    BHA derivative, antioxidative food and cosmetic...

    ≥99% Single isomer
  • A4806

    Ambroxol Hydrochloride

    Expectorant.

    ≥98%
  • P3441

    PIK-294

    p110δ PI3K inhibitor.

    ≥98%
  • B8276

    Butyric Acid Sodium

    HDAC inhibitor, RNA splicing modulator.

    ≥98%
  • A7210

    L-(+)-Ascorbic Acid

    Form of vitamin C found in various plant and fo...

    ≥98%
  • G4597

    18β-Glycyrrhetinic Acid

    Triterpene glycoside found in Glycyrrhiza; 15-H...

    ≥98%
  • A7578

    Astragaloside IV

    Found in Astragalus membranaceus.

    ≥98%
  • S0245

    Salmeterol

    β2-adrenergic agonist.

    ≥98%
  • C9779

    Cytisine

    Alkaloid found in Fabaceae family plants; α3β...

    ≥98%
  • F4481

    Flurbiprofen

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • D1748

    Demeclocycline Hydrochloride

    Tetracycline; protein translation inhibitor, po...

    ≥85%
  • T2404

    TG101348

    JAK2 inhibitor.

    ≥98%
  • F4581

    5-Fluorocytosine

    Synthetic antifungal.

    ≥98%
  • C6935

    Crizotinib

    ALK, ROS1, c-MET inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only